Health
NK cells combined with bispecific antibody display potent anti-tumor activity against lymphoma cells – News-Medical.Net
Cytokine-activated natural killer (NK) cells derived from donated umbilical cord blood, combined with an investigational bispecific antibody targeting CD16a and…
Cytokine-activated natural killer (NK) cells derived from donated umbilical cord blood, combined with an investigational bispecific antibody targeting CD16a and CD30 known as AFM13, displayed potent anti-tumor activity against CD30+ lymphoma cells, according to a new preclinical study from researchers at The University of Texas MD Anderson Cancer Center.
The findings were published today in Clinical Cancer Research, a journal of the American Association for Cancer Research. These results led to…
-
Noosa News23 hours agoHow Lily Steele-Park took her rapist to court and won
-
Noosa News24 hours agoE-biker charged with riding dangerously, assaulting cop
-
General22 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands
-
Business17 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today